{"DataElement":{"publicId":"6703580","version":"1","preferredName":"EGFR Gene Mutation Abnormality Identified Type","preferredDefinition":"Text term that represents the kind of EGFR gene mutation abnormality identified.","longName":"EGFR_MUT_ABN_TP","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6063521","version":"1","preferredName":"EGFR Gene Mutation Abnormality Identification","preferredDefinition":"This gene is involved in the epidermal growth factor signal transduction pathway._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._The procedure of having an identity established.","longName":"2240797v1.0:6060068v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"2240797","version":"1","preferredName":"EGFR Gene","preferredDefinition":"The EGFR gene at chromosome 7p12.3-p12.1 encodes the EGFreceptor, a cell surface transmembrane protein tyrosine kinase involved in regulation of cell growth and differentiation. The gene is not expressed in mitotically quiescent cells, except in the stomach where it controls the synthesis and release of digestive enzymes and gastric acid. EGFR tyrosine kinase activity is required for internalization or degradation of EGF-EGFR receptor complexes. EGFR signaling involves small RHO GTPases and EGFR trafficking involves small RAB GTPases.","longName":"C17757","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAB2D8EC-6CE2-68CB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-07","modifiedBy":"ONEDATA","dateModified":"2005-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6060068","version":"1","preferredName":"Mutation Abnormality Identification","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.:The procedure of having an identity established.","longName":"C45576:C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647B3BCD-7CC7-0A68-E053-F662850A93B4","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A47BEB-9E55-61AD-E053-F662850A9613","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6703552","version":"1","preferredName":"Mutation Abnormality Type","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._Something distinguishable as an identifiable class based on common qualities.","longName":"6703552v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"100","maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Exon 19 Deletion","valueDescription":"EGFR Exon 19 Deletion Mutation","ValueMeaning":{"publicId":"6703554","version":"1","preferredName":"EGFR Exon 19 Deletion Mutation","longName":"6703554","preferredDefinition":"In-frame deletions occurring within the exon 19-encoded part of the epidermal growth factor receptor (EGFR) kinase domain. These mutations are commonly seen in non-small cell lung cancer and are associated with increased sensitivity to EGFR tyrosine kinase inhibitors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Exon 19 Deletion Mutation","conceptCode":"C126892","definition":"In-frame deletions occurring within the exon 19-encoded part of the epidermal growth factor receptor (EGFR) kinase domain. These mutations are commonly seen in non-small cell lung cancer and are associated with increased sensitivity to EGFR tyrosine kinase inhibitors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D4F09E-2F93-62BE-E053-F662850ADAAC","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86D4F09E-2FAC-62BE-E053-F662850ADAAC","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","deletedIndicator":"No"},{"value":"L858R/other","valueDescription":"EGFR NP_005219.2:p.L858R Other","ValueMeaning":{"publicId":"6703555","version":"1","preferredName":"EGFR NP_005219.2:p.L858R Other","longName":"6703555","preferredDefinition":"A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L858R","conceptCode":"C98515","definition":"A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D4F09E-2FB9-62BE-E053-F662850ADAAC","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86D4F09E-2FD2-62BE-E053-F662850ADAAC","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6703551","version":"1","preferredName":"Mutation Abnormality Type","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.:Something distinguishable as an identifiable class based on common qualities.","longName":"C45576:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D4F09E-2F68-62BE-E053-F662850ADAAC","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D4F09E-2F79-62BE-E053-F662850ADAAC","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"SOKKERL","dateModified":"2019-05-01","changeDescription":"4-18-19 10042/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Theradex - 1","type":"Alternate Question Text","description":"EGFR mutation status","url":null,"context":"Theradex"},{"name":"If EGFR Mutation Identified,","type":"Preferred Question Text","description":"If EGFR Mutation Identified, which one?","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D5A60B-D239-4CD5-E053-F662850AA23B","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"SOKKERL","dateModified":"2019-05-01","changeDescription":"4-18-19 10042; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}